Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

EPIDEMIOLOGY, GENOTYPING. Edition No. 1

VDM Publishing House, July 2009, Pages: 188


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

This study is the first detailed analysis of Candida
infections in burn patients in an Indian hospital.
Burn patients are never subjected to fungal culture
or given antifungals unless oral thrush develops.
All attention goes to treat life threatening gram-
negative bacterial septicemia. Often there is no
significant bacterial culture positivity, still the
patient deteriorates and dies. Study suggests that
in such instances, patient might be suffering from
fungal septicemia. This study is an attempt,
expected to lead to better clinical management of
burn patients. Interactions occurring between
various bacteria and fungi in the burn wound are
also analyzed, which may altogether alter the
clinical prognosis of the patient. In agreement with
earlier in vitro studies, it is observed that
Pseudomonas significantly inhibits growth of Candida
in vivo in the burn wound, either alone or in
combination with other bacteria suggesting that
Pseudomonas has an inhibitory effect on the growth
of Candida. Results also suggest the involvement of
some unknown genes and transcription factors in
causing azole resistance in intrinsically resistant
C. albicans clinical isolates.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds